| 000 | 01902 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250517111251.0 | ||
| 264 | 0 | _c20180129 | |
| 008 | 201801s 0 0 eng d | ||
| 022 | _a1091-6490 | ||
| 024 | 7 |
_a10.1073/pnas.1608858113 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSana, Thibault G | |
| 245 | 0 | 0 |
_aSalmonella Typhimurium utilizes a T6SS-mediated antibacterial weapon to establish in the host gut. _h[electronic resource] |
| 260 |
_bProceedings of the National Academy of Sciences of the United States of America _c08 2016 |
||
| 300 |
_aE5044-51 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aAntibiosis |
| 650 | 0 | 4 |
_aBacterial Proteins _xbiosynthesis |
| 650 | 0 | 4 |
_aBile Acids and Salts _xpharmacology |
| 650 | 0 | 4 |
_aCulture Media _xchemistry |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGastrointestinal Microbiome _xdrug effects |
| 650 | 0 | 4 |
_aGastrointestinal Tract _xmicrobiology |
| 650 | 0 | 4 | _aGenomic Islands |
| 650 | 0 | 4 |
_aKlebsiella oxytoca _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred C57BL |
| 650 | 0 | 4 |
_aSalmonella Infections, Animal _xmicrobiology |
| 650 | 0 | 4 |
_aSalmonella typhimurium _xgenetics |
| 650 | 0 | 4 |
_aType VI Secretion Systems _xgenetics |
| 650 | 0 | 4 |
_aVirulence Factors _xbiosynthesis |
| 700 | 1 | _aFlaugnatti, Nicolas | |
| 700 | 1 | _aLugo, Kyler A | |
| 700 | 1 | _aLam, Lilian H | |
| 700 | 1 | _aJacobson, Amanda | |
| 700 | 1 | _aBaylot, Virginie | |
| 700 | 1 | _aDurand, Eric | |
| 700 | 1 | _aJournet, Laure | |
| 700 | 1 | _aCascales, Eric | |
| 700 | 1 | _aMonack, Denise M | |
| 773 | 0 |
_tProceedings of the National Academy of Sciences of the United States of America _gvol. 113 _gno. 34 _gp. E5044-51 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1073/pnas.1608858113 _zAvailable from publisher's website |
| 999 |
_c26309456 _d26309456 |
||